Appili Therapeutics Inc. (OTCMKTS:APLIF) (TSX: APLI) is down 6% in a week. The company has announced its fiscal Q3 2022 financial and operational results for the quarter ending December 31, 2021. Market Stats On Monday, APLIF stock ended flat at $0.0927 with more than 2.3k shares, compared to its average volume of 91K shares. The …